172 related articles for article (PubMed ID: 24742849)
1. The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Day A; Abramson AK; Patel M; Warren RB; Menter MA
J Am Acad Dermatol; 2014 May; 70(5):821.e1-19. PubMed ID: 24742849
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of oculocutaneous disease: Part I. Infectious, inflammatory, and genetic causes of oculocutaneous disease.
Horner ME; Abramson AK; Warren RB; Swanson S; Menter MA
J Am Acad Dermatol; 2014 May; 70(5):795.e1-25. PubMed ID: 24742848
[TBL] [Abstract][Full Text] [Related]
3. Periocular cutaneous malignancies: a review of the literature.
Slutsky JB; Jones EC
Dermatol Surg; 2012 Apr; 38(4):552-69. PubMed ID: 22404129
[TBL] [Abstract][Full Text] [Related]
4. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and behavior of eyelid carcinoma (basal cell, squamous cell sebaceous gland, and malignant melanoma).
Loeffler M; Hornblass A
Ophthalmic Surg; 1990 Jul; 21(7):513-8. PubMed ID: 2204856
[TBL] [Abstract][Full Text] [Related]
6. A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
Scheinfeld N
J Drugs Dermatol; 2007 Mar; 6(3):352-5. PubMed ID: 17373201
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of skin neoplasms of the head and neck.
Kraft S; Granter SR
Arch Pathol Lab Med; 2014 Jun; 138(6):759-87. PubMed ID: 24878016
[TBL] [Abstract][Full Text] [Related]
8. The skin, the eye, and systemic disease.
Callen JP
Cutis; 1979 Nov; 24(5):501-11. PubMed ID: 117978
[TBL] [Abstract][Full Text] [Related]
9. Bilateral ocular surface squamous neoplasia with bilateral periocular basal cell carcinoma in a case of xeroderma pigmentosum.
Agarwal R; Chawla B; Asif MI; Pujari A
BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29197837
[TBL] [Abstract][Full Text] [Related]
10. [Ocular manifestations of xeroderma pigmentosum (report of 5 cases)].
Ben Rayana N; Ruhomauly H; Limaiem R; Mahjoub H; Ben Hadj Hamida F
Tunis Med; 1998; 76(8-9):263-7. PubMed ID: 9810864
[No Abstract] [Full Text] [Related]
11. Malignant tumor of the eyelid--clinical survey during 22-year period.
Abe M; Ohnishi Y; Hara Y; Shinoda Y; Jingu K
Jpn J Ophthalmol; 1983; 27(1):175-84. PubMed ID: 6855011
[TBL] [Abstract][Full Text] [Related]
12. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
Grampurohit VU; Dinesh US; Rao R
J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
[TBL] [Abstract][Full Text] [Related]
13. Retinoids in the management of non-melanoma skin cancer and melanoma.
Craven NM; Griffiths CE
Cancer Surv; 1996; 26():267-88. PubMed ID: 8783579
[No Abstract] [Full Text] [Related]
14. Periocular tumors.
Salasche SJ; Shore JW; Olbricht SM
Dermatol Clin; 1992 Oct; 10(4):669-85. PubMed ID: 1395151
[TBL] [Abstract][Full Text] [Related]
15. [Current diagnostic criteria of PHACES syndrome].
Honkisz I; Szymik-Kantorowicz S; Prokurat A
Med Wieku Rozwoj; 2011; 15(2):143-50. PubMed ID: 22002046
[TBL] [Abstract][Full Text] [Related]
16. [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].
Chronopoulos A; Pleyer U; Mockenhaupt M
Klin Monbl Augenheilkd; 2012 May; 229(5):534-9. PubMed ID: 22592345
[TBL] [Abstract][Full Text] [Related]
17. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
Boruah PK; Bolesta S; Shetty SM
Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
[TBL] [Abstract][Full Text] [Related]
18. Neonate presenting with a midline supraumbilical raphe.
Heinisch S; Prather HB; English JC; Gehris RP
J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):366-8. PubMed ID: 24075092
[No Abstract] [Full Text] [Related]
19. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Wilkins J; Morrison L; White CR
Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
[TBL] [Abstract][Full Text] [Related]
20. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
